BMS-345541 Hydrochloride: Selective IKK Inhibition for NF-κB Pathway Research

Executive Summary: BMS-345541 hydrochloride is a highly selective inhibitor of IκB kinase isoforms IKK-1 and IKK-2, with IC₅₀ values of 4 μM and 0.3 μM, respectively (APExBIO). It blocks NF-κB-dependent transcription of key pro-inflammatory cytokines such as TNFα, IL-1β, IL-6, and IL-8 in both in vitro and in vivo models (Du et al., 2021). BMS-345541 induces apoptosis and G2/M phase cell cycle arrest in T-cell acute lymphoblastic leukemia (T-ALL) cells, which suggests its potential to overcome chemoresistance [ref]. The compound demonstrates high water solubility (≥60 mg/mL), 100% oral bioavailability in animal models, and exceptional selectivity, not inhibiting other serine/threonine or tyrosine kinases. Proper storage at -20°C ensures stability for several months, but solutions should be used promptly. APExBIO offers validated product quality and documentation for research use.

Biological Rationale

The NF-κB pathway is a central regulator of inflammation, immunity, cell proliferation, and survival. IκB kinases (IKK-1/IKKα and IKK-2/IKKβ) phosphorylate IκB proteins, triggering their degradation and releasing NF-κB to enter the nucleus and activate gene transcription [Du et al., 2021]. Dysregulation of NF-κB signaling is implicated in chronic inflammation, autoimmune disorders, and cancer, including chemoresistant T-cell acute lymphoblastic leukemia (T-ALL) [see strategic context]. Selective inhibition of the IKK complex enables precise modulation of NF-κB target gene expression. BMS-345541 hydrochloride provides researchers with a tool to dissect these pathways, offering high specificity and minimal off-target effects [APExBIO].

Mechanism of Action of BMS-345541 hydrochloride

BMS-345541 hydrochloride binds to an allosteric site on the IKK enzyme complex. This binding blocks ATP access and selectively inhibits IKK-1 and IKK-2 enzymatic activity, with IC₅₀ values of 4 μM and 0.3 μM, respectively [APExBIO]. This inhibition prevents phosphorylation and subsequent proteasomal degradation of IκB, thereby retaining NF-κB in the cytoplasm and suppressing downstream transcription of pro-inflammatory cytokines (TNFα, IL-1β, IL-6, IL-8). Notably, BMS-345541 does not inhibit other serine/threonine or tyrosine kinases and does not interfere with alternative signaling cascades, confirming its selectivity [ref]. The compound's ability to induce apoptosis and G2/M cell cycle arrest in T-ALL models is attributed to disrupted NF-κB-mediated survival signaling [Du et al., 2021].

Evidence & Benchmarks

• BMS-345541 hydrochloride inhibits IKK-2 with an IC₅₀ of 0.3 μM and IKK-1 with 4 μM, determined via kinase assays (https://www.apexbt.com/bms345541-hydrochloride.html).
• In cellular assays, BMS-345541 selectively blocks TNFα-induced IκB phosphorylation and prevents NF-κB nuclear translocation, demonstrated in multiple cell lines (https://doi.org/10.1038/s41467-021-27367-5).
• The compound does not inhibit unrelated serine/threonine or tyrosine kinases at concentrations up to 100 μM, verified via kinase selectivity profiling (https://5-formyl-ctp.com/index.php?g=Wap&m=Article&a=detail&id=10823).
• BMS-345541 induces apoptosis and G2/M cell cycle arrest in T-ALL cell lines, overcoming chemoresistance in vitro and in animal models (https://ifg-1.com/index.php?g=Wap&m=Article&a=detail&id=16194).
• Oral administration in animal models yields 100% bioavailability and significant suppression of TNFα production in inflammatory challenge studies (https://www.apexbt.com/bms345541-hydrochloride.html).
• Stock solutions stored at -20°C are stable for several months, but working solutions should be freshly prepared to maintain activity (https://bms345541hydrochloride.com/index.php?g=Wap&m=Article&a=detail&id=14377).

Applications, Limits & Misconceptions

BMS-345541 hydrochloride serves as a precision research tool for studies of:

• NF-κB pathway inhibition in inflammation, immunity, and cell death.
• Cytokine signaling suppression (TNFα, IL-1β, IL-6, IL-8), relevant for autoimmunity and chronic inflammatory diseases.
• Apoptosis induction and cell cycle arrest in chemoresistant T-ALL and other cancer models.
• Dissection of IKK/NF-κB signaling in fundamental and translational research contexts.

This article builds on the practical guidance provided in "BMS-345541 Hydrochloride (SKU A3248): Reliable IKK Inhibitor Optimization" by systematically mapping quantitative evidence and clarifying limitations for advanced users.

Common Pitfalls or Misconceptions

• Not a pan-kinase inhibitor: BMS-345541 does not inhibit kinases outside the IKK family at relevant concentrations. It is ineffective for broad-spectrum kinase blockade.
• Not suitable for long-term solution storage: Working solutions degrade and should be used promptly after preparation, even though stock is stable at -20°C.
• Limited solubility in organic solvents: BMS-345541 hydrochloride is insoluble in ethanol and DMSO. Only water (≥60 mg/mL) should be used for solution preparation.
• Not a direct necroptosis modulator: While IKK/NF-κB signaling intersects with cell death pathways, BMS-345541 does not directly inhibit RIPK1 or necroptosis effectors (see Du et al., 2021).
• No clinical approval: BMS-345541 hydrochloride is a research-use-only reagent and is not approved for human therapeutic administration.

Workflow Integration & Parameters

BMS-345541 hydrochloride is supplied as a water-soluble powder by APExBIO under SKU A3248. For in vitro studies, stock solutions can be prepared in sterile water at concentrations up to ≥60 mg/mL. For in vivo work, oral administration has demonstrated full bioavailability in rodent models, with effective inhibition of TNFα production [APExBIO]. Storage at -20°C is required for long-term stability; avoid repeated freeze-thaw cycles. Working dilutions should be freshly prepared and used immediately. Standard concentrations for IKK inhibition in cellular assays range from 0.5–10 μM. For a comprehensive review of application scenarios and troubleshooting, consult our optimization guide; this article extends those recommendations with updated selectivity and stability data.

Conclusion & Outlook

BMS-345541 hydrochloride is a selective, well-validated IKK inhibitor that empowers researchers to probe NF-κB signaling with precision. Its unique combination of potency, specificity, water solubility, and robust bioavailability in animal models makes it a gold-standard tool for dissecting inflammation, apoptosis, and chemoresistance mechanisms in cancer biology. For the latest strategic context and experimental design considerations, see this mechanistic review; this article provides an updated, evidence-driven dossier focused on product handling and quantitative benchmarks. Researchers should follow best practices for solution preparation and storage to maximize reproducibility. BMS-345541 hydrochloride, available from APExBIO, remains indispensable for foundational and translational studies in the IKK/NF-κB pathway. For further details and ordering information, visit the BMS-345541 hydrochloride product page.